Karuna Therapeutics Stock Cash Per Share
Karuna Therapeutics fundamentals help investors to digest information that contributes to Karuna Therapeutics' financial success or failures. It also enables traders to predict the movement of Karuna Stock. The fundamental analysis module provides a way to measure Karuna Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Karuna Therapeutics stock.
Karuna |
Karuna Therapeutics Company Cash Per Share Analysis
Karuna Therapeutics' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Karuna Therapeutics Cash Per Share | 13.60 X |
Most of Karuna Therapeutics' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Karuna Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Karuna Therapeutics has a Cash Per Share of 13.6 times. This is 212.64% higher than that of the Biotechnology sector and 214.09% higher than that of the Health Care industry. The cash per share for all United States stocks is 171.46% lower than that of the firm.
Karuna Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Karuna Therapeutics' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Karuna Therapeutics could also be used in its relative valuation, which is a method of valuing Karuna Therapeutics by comparing valuation metrics of similar companies.Karuna Therapeutics is currently under evaluation in cash per share category among its peers.
Karuna Fundamentals
Return On Equity | -0.36 | |||
Return On Asset | -0.25 | |||
Operating Margin | (755.64) % | |||
Current Valuation | 11.35 B | |||
Shares Outstanding | 38.2 M | |||
Shares Owned By Insiders | 4.98 % | |||
Shares Owned By Institutions | 86.32 % | |||
Number Of Shares Shorted | 1.97 M | |||
Price To Earning | (19.88) X | |||
Price To Book | 10.05 X | |||
Price To Sales | 19,265 X | |||
Revenue | 654 K | |||
Gross Profit | 10.64 M | |||
EBITDA | (493.08 M) | |||
Net Income | (433.68 M) | |||
Cash And Equivalents | 407.41 M | |||
Cash Per Share | 13.60 X | |||
Total Debt | 16.69 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 17.77 X | |||
Book Value Per Share | 32.94 X | |||
Cash Flow From Operations | (385.82 M) | |||
Short Ratio | 3.60 X | |||
Earnings Per Share | (11.74) X | |||
Price To Earnings To Growth | 1.46 X | |||
Target Price | 324.17 | |||
Number Of Employees | 339 | |||
Beta | 1.15 | |||
Market Capitalization | 12.6 B | |||
Total Asset | 1.34 B | |||
Retained Earnings | (997.89 M) | |||
Working Capital | 1.25 B | |||
Current Asset | 6.24 M | |||
Current Liabilities | 8.73 M | |||
Net Asset | 1.34 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Karuna Stock
If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |